Cipla Launches Generic Liraglutide in US
MUMBAI, India & WARREN, N.J., USA – February 27, 2026 Cipla Limited announced the U.S. launch of Liraglutide Injection...
Alzheimer’s Disease Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody NSCLC Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
MUMBAI, India & WARREN, N.J., USA – February 27, 2026 Cipla Limited announced the U.S. launch of Liraglutide Injection...
Dateline – Mumbai, India, November 5, 2025:Piramal Pharma Limited (NSE: PPLPHARMA, BSE: 543635), a leading global pharmaceutical, health and...
September 3, 2025 – Mumbai & Naples – Lupin Limited announced U.S. FDA approval for its Risperidone extended-release injectable...
